| BM |
body mass index |
| CE |
Conformité Européenne |
| CI |
confidence interval |
| COPD |
chronic obstructive pulmonary disease |
| CT |
computed tomography |
| CTTB |
computed tomography guided transthoracic biopsy |
| EBUS |
endobronchial ultrasound |
| ENB |
electromagnetic navigation bronchoscopy |
| FDA |
Food and Drugs Administration |
| GP |
general practitioner |
| GRADE |
grading of recommendations assessment, development and evaluation |
| ICER |
incremental cost-effectiveness ratio |
| IQR |
interquartile range |
| mm |
millimetre |
| NCA |
North Cancer Alliance |
| NHS |
National Health Service |
| NMA |
network meta-analysis |
| NR |
not reported |
| OR |
odds ratio |
| PHS |
Public Health Scotland |
| QUADAS-2 |
Quality Assessment of Diagnostic Accuracy Studies version 2 |
| QUADAS-C |
Quality Assessment of Diagnostic Accuracy Studies – comparative |
| QALY |
quality-adjusted life year |
| RAB |
robotic-assisted bronchoscopy |
| RCT |
randomised controlled trial |
| RR |
relative risk |
| SCAN |
South East Scotland Cancer Network |
| SD |
standard deviation |
| SHTG |
Scottish Health Technologies Group |
| UK |
United Kingdom |
| VBN |
virtual bronchoscopic navigation |
| WOSCAN |
West of Scotland Cancer NetworK |
Scottish Health Technologies Group (SHTG)
